John Zic, M.D.
- Professor of Medicine (Dermatology)
- Director, Vanderbilt Cutaneous Lymphoma Clinic
John Zic, M.D.
- Professor of Medicine (Dermatology)
- Director, Vanderbilt Cutaneous Lymphoma Clinic
john.zic@vumc.org
Research Program
-
Non-Programmatically Aligned
Departments/Affiliations
Provider Information
Profile
John Alan Zic, MD, earned his medical degree from the Vanderbilt University School of Medicine in Nashville, Tennessee. He then completed an internship in internal medicine and a residency in dermatology (serving as chief resident) at the University of Illinois at Chicago Hospital. Dr Zic currently is a Professor of Medicine in the Division of Dermatology of Vanderbilt University's School of Medicine and director of the Vanderbilt Cutaneous Lymphoma Clinic.
Dr. Zic has served as principal investigator in numerous studies on cutaneous lymphoma. He serves on the international editorial board of the American Journal of Drugs in Dermatology while also serving as a review for numerous journals. His primary research interests focus on variables predicting response and survival of patients with cutaneous lymphomas. He is a member of several professional organizations, including the American Academy of Dermatology, the International Society for Cutaneous Lymphoma, the Society for Investigative Dermatology, and the Tennessee Dermatology Society.
While at Vanderbilt University, Dr. Zic has earned a Master Clinical Teacher appointment, a CANDLE Award for medical student mentoring/teaching, and a Grant Liddle Award for research mentoring of young physicians.
Education
- M.D. - Vanderbilt University, 1991
- Residency - University of Illinois Medical Center, 1995
- Internship - University of Chicago Medical Center, 1992
Research Emphasis
cutaneous T cell lymphoma, mycosis fungoides, photopheresis, lymphomatoid papulosis, primary cutaneous ALCL, dermatopharmacology
Research Description
.
Publications
- McGirt LY, Degesys CA, Johnson VE, Zic JA, Zwerner JP, Eischen CM. TOX expression and role in CTCL. J Eur Acad Dermatol Venereol [print-electronic]. 2016 Jun 6/26/2016; PMID: 27345620, DOI: 10.1111/jdv.13651, ISSN: 1468-3083.
- Oluwole OO, Zic JA, Douds JJ, Ann Thompson M, Greer JP. Cutaneous manifestations and management of hematologic neoplasms. Semin. Oncol [print-electronic]. 2016 Jun; 43(3): 370-83. PMID: 27178691, PII: S0093-7754(16)00046-4, DOI: 10.1053/j.seminoncol.2016.02.021, ISSN: 1532-8708.
- Patrawala SA, Broussard KC, Wang L, Zic JA. Tumor stage mycosis fungoides: a single-center study on clinicopathologic features, treatments, and patient outcome. Dermatol. Online J. 2016 May 5/15/2016; 22(5): PMID: 27617516, ISSN: 1087-2108.
- Zic JA. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome. Dermatol Clin [print-electronic]. 2015 Oct; 33(4): 765-76. PMID: 26433848, PII: S0733-8635(15)00056-X, DOI: 10.1016/j.det.2015.05.011, ISSN: 1558-0520.
- McGirt LY, Jia P, Baerenwald DA, Duszynski RJ, Dahlman KB, Zic JA, Zwerner JP, Hucks D, Dave U, Zhao Z, Eischen CM. Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood [print-electronic]. 2015 Jul 7/23/2015; 126(4): 508-19. PMID: 26082451, PMCID: PMC4513251, PII: blood-2014-11-611194, DOI: 10.1182/blood-2014-11-611194, ISSN: 1528-0020.
- Schmidt AN, Zic JA, Boyd AS. Pedicure-associated Mycobacterium chelonae infection in a hospitalized patient. J. Am. Acad. Dermatol [print-electronic]. 2014 Dec; 71(6): e248-50. PMID: 25454047, PII: S0190-9622(14)01804-0, DOI: 10.1016/j.jaad.2014.08.012, ISSN: 1097-6787.
- Bichakjian CK, Olencki T, Alam M, Andersen JS, Berg D, Bowen GM, Cheney RT, Daniels GA, Glass LF, Grekin RC, Grossman K, Ho AL, Lewis KD, Lydiatt DD, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Perlis CS, Shaha AR, Thorstad WL, Tuli M, Urist MM, Wang TS, Werchniak AE, Wong SL, Zic JA, McMillian N, Hoffman K, Ho M. Dermatofibrosarcoma protuberans, version 1.2014. J Natl Compr Canc Netw. 2014 Jun; 12(6): 863-8. PMID: 24925197, PII: 12/6/863.
- McGirt LY, Adams CM, Baerenwald DA, Zwerner JP, Zic JA, Eischen CM. MiR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma. J. Invest. Dermatol [print-electronic]. 2014 Apr; 134(4): 1101-7. PMID: 24304814, PMCID: PMC3961555, PII: S0022-202X(15)36714-2, DOI: 10.1038/jid.2013.461, ISSN: 1523-1747.
- Mask-Bull L, Likhari SB, Zic JA, Greer JP. Hemagglutination during photopheresis. J. Am. Acad. Dermatol. 2014 Mar; 70(3): e61-2. PMID: 24528919, PII: S0190-9622(13)01154-7, DOI: 10.1016/j.jaad.2013.10.037, ISSN: 1097-6787.
- Miller SJ, Alam M, Andersen JS, Berg D, Bichakjian CK, Bowen GM, Cheney RT, Glass LF, Grekin RC, Ho AL, Kessinger A, Liegeois N, Lydiatt DD, Michalski J, Morrison WH, Nehal KS, Nelson KC, Nghiem P, Olencki T, Perlis CS, Shaha AR, Tuli M, Urist MM, Wang LC, Zic JA, . Dermatofibrosarcoma protuberans. J Natl Compr Canc Netw. 2012 Mar; 10(3): 312-8. PMID: 22393193, PII: 10/3/312.
